Wang Shuyuan, Solenov Evgeniy I, Yang Baoxue
State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China.
Institute of Cytology and Genetics, SB RAS, Novosibirsk, Russia.
Adv Exp Med Biol. 2023;1398:317-330. doi: 10.1007/978-981-19-7415-1_22.
Aquaporins (AQP) working as membrane channels facilitated water transport, play vital roles in various physiological progress including cell migration, energy metabolism, inflammation, etc. They are quite important drug targets, but elusive for discovery due to their undruggable properties. In this chapter, we summarized most fluently used methods for screening AQP inhibitors, including cell swelling assay, cell shrinking assay, and stopped-flow assay. And three classes of AQP inhibitors have been discussed, including metal-related inhibitors, quaternary ammonium salts, and small molecule inhibitors which further divided into four parts, sulfanilamide analogies, TGN-020, antiepileptic drugs, and others. It has been suggested that although they showed inhibition effects on AQP1, AQP3, AQP4, AQP7, or AQP9 in some researches, none of them could be asserted as AQP inhibitors to some extent. Discovering AQP inhibitors is a big challenge, but if successful, it will be a great contribution for human health.
水通道蛋白(AQP)作为膜通道促进水的运输,在包括细胞迁移、能量代谢、炎症等各种生理过程中发挥着至关重要的作用。它们是非常重要的药物靶点,但由于其难以成药的特性而难以被发现。在本章中,我们总结了最常用的筛选AQP抑制剂的方法,包括细胞肿胀试验、细胞收缩试验和停流试验。并且讨论了三类AQP抑制剂,包括金属相关抑制剂、季铵盐以及小分子抑制剂,小分子抑制剂又进一步分为四个部分,即磺胺类类似物、TGN-020、抗癫痫药物及其他。有人提出,尽管它们在一些研究中对AQP1、AQP3、AQP4、AQP7或AQP9表现出抑制作用,但在某种程度上,没有一种能被断言为AQP抑制剂。发现AQP抑制剂是一项巨大的挑战,但如果成功,将对人类健康做出巨大贡献。